US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 4.020
  • +0.030+0.75%
Close Jun 4 16:00 ET
  • 4.020
  • 0.0000.00%
Post 16:02 ET
144.94MMarket Cap-2716P/E (TTM)

scPharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.32%-17.7M
-71.34%-59.24M
-28.06%-15.16M
-64.12%-13.45M
-97.09%-14.14M
-123.83%-16.49M
-27.35%-34.58M
-66.77%-11.84M
-58.62%-8.2M
-14.42%-7.18M
Net income from continuing operations
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
-55.10%-10.16M
-37.31%-9.7M
Operating gains losses
-210.23%-3.12M
-173.33%-3.65M
---2.44M
--36K
---243K
---1.01M
---1.34M
----
----
----
Depreciation and amortization
-51.43%51K
33.76%626K
16.67%140K
130.51%272K
-14.84%109K
2.94%105K
6.85%468K
8.11%120K
5.36%118K
17.43%128K
Other non cash items
24.95%616K
145.02%2.17M
2.61%590K
514.29%559K
403.85%524K
332.46%493K
59.57%884K
299.31%575K
-38.10%91K
82.46%104K
Change In working capital
53.52%-2.48M
-1,706.00%-6.32M
79.25%-515K
-25.71%734K
-173.38%-1.2M
-980.57%-5.34M
86.53%-350K
-267.16%-2.48M
96.81%988K
2,173.42%1.64M
-Change in receivables
57.29%-1.28M
---4.49M
---314K
---2.57M
--1.39M
---3M
--0
--0
--0
--0
-Change in inventory
68.28%-758K
-518.62%-7.61M
-39.51%-1.72M
---1.29M
---2.21M
---2.39M
---1.23M
---1.23M
--0
--0
-Change in prepaid assets
261.69%422K
124.92%221K
61.80%-646K
8,320.00%411K
15.27%717K
-239.57%-261K
-279.06%-887K
-43.91%-1.69M
-100.63%-5K
137.40%622K
-Change in payables and accrued expense
-371.92%-862K
214.43%5.56M
392.26%2.16M
320.85%4.18M
-208.37%-1.1M
146.55%317K
174.71%1.77M
-12.02%439K
435.47%993K
397.95%1.02M
Cash from discontinued investing activities
Operating cash flow
-7.32%-17.7M
-71.34%-59.24M
-28.06%-15.16M
-64.12%-13.45M
-97.09%-14.14M
-123.83%-16.49M
-27.35%-34.58M
-66.77%-11.84M
-58.62%-8.2M
-14.42%-7.18M
Investing cash flow
Cash flow from continuing investing activities
318.84%29.32M
143.54%19.97M
161.55%26.46M
-312.58%-22.93M
1,194.89%9.43M
154.73%7M
-242.73%-45.86M
-1,055.17%-42.99M
13.27%10.78M
-115.94%-861K
Net PPE purchase and sale
----
-90.48%-40K
---37K
--0
----
----
-133.33%-21K
--0
-50.00%-15K
--0
Net investment purchase and sale
318.84%29.32M
143.64%20.01M
161.64%26.5M
-312.29%-22.93M
1,195.24%9.43M
154.76%7M
-242.62%-45.84M
-1,055.38%-42.99M
13.30%10.8M
-115.94%-861K
Cash from discontinued investing activities
Investing cash flow
318.84%29.32M
143.54%19.97M
161.55%26.46M
-312.58%-22.93M
1,194.89%9.43M
154.73%7M
-242.73%-45.86M
-1,055.17%-42.99M
13.27%10.78M
-115.94%-861K
Financing cash flow
Cash flow from continuing financing activities
-99.89%15K
-80.77%14.85M
-99.45%467K
102.75%68K
125.29%611K
652.80%13.7M
3,152.53%77.23M
3,541.86%84.6M
-2.48M
-2.42M
Net issuance payments of debt
----
--0
--0
--0
----
----
1,292.04%29.8M
1,592.04%37.3M
---2.5M
---2.5M
Net common stock issuance
--0
-70.61%14.04M
--0
--0
--334K
--13.7M
--47.77M
--47.77M
--0
--0
Proceeds from stock option exercised by employees
--15K
274.19%812K
424.72%467K
195.65%68K
229.76%277K
--0
325.49%217K
-27.64%89K
--23K
--84K
Net other financing activities
----
----
----
----
----
----
-583.95%-554K
----
----
----
Cash from discontinued financing activities
Financing cash flow
-99.89%15K
-80.77%14.85M
-99.45%467K
102.75%68K
125.29%611K
652.80%13.7M
3,152.53%77.23M
3,541.86%84.6M
---2.48M
---2.42M
Net cash flow
Beginning cash position
-34.29%46.81M
-4.31%71.24M
-15.50%35.04M
72.51%71.35M
45.63%75.45M
-4.31%71.24M
3.40%74.45M
-47.84%41.47M
-44.96%41.36M
-31.84%51.81M
Current changes in cash
176.32%11.63M
-661.74%-24.43M
-60.46%11.77M
-32,809.91%-36.31M
60.74%-4.1M
118.60%4.21M
-230.95%-3.21M
688.96%29.77M
-97.45%111K
-1,104.15%-10.45M
End cash Position
-22.54%58.45M
-34.29%46.81M
-34.29%46.81M
-15.50%35.04M
72.51%71.35M
45.63%75.45M
-4.31%71.24M
-4.31%71.24M
-47.84%41.47M
-44.96%41.36M
Free cash flow
-7.32%-17.7M
-71.35%-59.28M
-28.37%-15.2M
-63.82%-13.45M
-97.13%-14.14M
-123.65%-16.49M
-27.39%-34.6M
-66.79%-11.84M
-58.61%-8.21M
-14.42%-7.18M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.32%-17.7M-71.34%-59.24M-28.06%-15.16M-64.12%-13.45M-97.09%-14.14M-123.83%-16.49M-27.35%-34.58M-66.77%-11.84M-58.62%-8.2M-14.42%-7.18M
Net income from continuing operations -25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M-55.10%-10.16M-37.31%-9.7M
Operating gains losses -210.23%-3.12M-173.33%-3.65M---2.44M--36K---243K---1.01M---1.34M------------
Depreciation and amortization -51.43%51K33.76%626K16.67%140K130.51%272K-14.84%109K2.94%105K6.85%468K8.11%120K5.36%118K17.43%128K
Other non cash items 24.95%616K145.02%2.17M2.61%590K514.29%559K403.85%524K332.46%493K59.57%884K299.31%575K-38.10%91K82.46%104K
Change In working capital 53.52%-2.48M-1,706.00%-6.32M79.25%-515K-25.71%734K-173.38%-1.2M-980.57%-5.34M86.53%-350K-267.16%-2.48M96.81%988K2,173.42%1.64M
-Change in receivables 57.29%-1.28M---4.49M---314K---2.57M--1.39M---3M--0--0--0--0
-Change in inventory 68.28%-758K-518.62%-7.61M-39.51%-1.72M---1.29M---2.21M---2.39M---1.23M---1.23M--0--0
-Change in prepaid assets 261.69%422K124.92%221K61.80%-646K8,320.00%411K15.27%717K-239.57%-261K-279.06%-887K-43.91%-1.69M-100.63%-5K137.40%622K
-Change in payables and accrued expense -371.92%-862K214.43%5.56M392.26%2.16M320.85%4.18M-208.37%-1.1M146.55%317K174.71%1.77M-12.02%439K435.47%993K397.95%1.02M
Cash from discontinued investing activities
Operating cash flow -7.32%-17.7M-71.34%-59.24M-28.06%-15.16M-64.12%-13.45M-97.09%-14.14M-123.83%-16.49M-27.35%-34.58M-66.77%-11.84M-58.62%-8.2M-14.42%-7.18M
Investing cash flow
Cash flow from continuing investing activities 318.84%29.32M143.54%19.97M161.55%26.46M-312.58%-22.93M1,194.89%9.43M154.73%7M-242.73%-45.86M-1,055.17%-42.99M13.27%10.78M-115.94%-861K
Net PPE purchase and sale -----90.48%-40K---37K--0---------133.33%-21K--0-50.00%-15K--0
Net investment purchase and sale 318.84%29.32M143.64%20.01M161.64%26.5M-312.29%-22.93M1,195.24%9.43M154.76%7M-242.62%-45.84M-1,055.38%-42.99M13.30%10.8M-115.94%-861K
Cash from discontinued investing activities
Investing cash flow 318.84%29.32M143.54%19.97M161.55%26.46M-312.58%-22.93M1,194.89%9.43M154.73%7M-242.73%-45.86M-1,055.17%-42.99M13.27%10.78M-115.94%-861K
Financing cash flow
Cash flow from continuing financing activities -99.89%15K-80.77%14.85M-99.45%467K102.75%68K125.29%611K652.80%13.7M3,152.53%77.23M3,541.86%84.6M-2.48M-2.42M
Net issuance payments of debt ------0--0--0--------1,292.04%29.8M1,592.04%37.3M---2.5M---2.5M
Net common stock issuance --0-70.61%14.04M--0--0--334K--13.7M--47.77M--47.77M--0--0
Proceeds from stock option exercised by employees --15K274.19%812K424.72%467K195.65%68K229.76%277K--0325.49%217K-27.64%89K--23K--84K
Net other financing activities -------------------------583.95%-554K------------
Cash from discontinued financing activities
Financing cash flow -99.89%15K-80.77%14.85M-99.45%467K102.75%68K125.29%611K652.80%13.7M3,152.53%77.23M3,541.86%84.6M---2.48M---2.42M
Net cash flow
Beginning cash position -34.29%46.81M-4.31%71.24M-15.50%35.04M72.51%71.35M45.63%75.45M-4.31%71.24M3.40%74.45M-47.84%41.47M-44.96%41.36M-31.84%51.81M
Current changes in cash 176.32%11.63M-661.74%-24.43M-60.46%11.77M-32,809.91%-36.31M60.74%-4.1M118.60%4.21M-230.95%-3.21M688.96%29.77M-97.45%111K-1,104.15%-10.45M
End cash Position -22.54%58.45M-34.29%46.81M-34.29%46.81M-15.50%35.04M72.51%71.35M45.63%75.45M-4.31%71.24M-4.31%71.24M-47.84%41.47M-44.96%41.36M
Free cash flow -7.32%-17.7M-71.35%-59.28M-28.37%-15.2M-63.82%-13.45M-97.13%-14.14M-123.65%-16.49M-27.39%-34.6M-66.79%-11.84M-58.61%-8.21M-14.42%-7.18M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg